AVEO initiates Phase 2 colorectal cancer trial
Linkedin

AVEO initiates Phase 2 colorectal cancer trial

Toronto : Canada | Dec 22, 2011 at 4:07 PM PST
Source: Pharmaceutical Industry News
XX XX
Views: Pending
 
Patients will be randomized to one of the two treatments arms in a 2:1 ratio (168 patients in the tivozanib arm and 84 patients in the bevacizumab arm). RCC to inform our clinical development strategy in an effort to bring tivozanib to patients who will benefit most," Slichenmyer added. FULL ARTICLE AT Pharmaceutical Industry News
 
  • Clear
  • Share:
  • Share
  • Clear
  • Clear
  • Clear
  • Clear
 
  • Credibility
  • Wait... Flag
 
 
Advertisement
 

More From Allvoices



Use of this site is governed by our Terms of Use Agreement and Privacy Policy.

© Allvoices, Inc. 2008-2014. All rights reserved. Powered by PulsePoint.